Your support fuels our research to #EndALS! Donate Now



Originally introduced to control blood sugar levels in type 2 diabetics, metformin in more recent years grabbed ALS researchers’ attention due to its ability to combat inflammation. Metformin is also being developed as a treatment for Huntington’s disease and multiple sclerosis.


Type: Small Molecule
Stage: Preclinical
Status: Inactive
Sponsor: Hammersmith Hospital

TDI Says:

Based on the results of preclinical studies, we think that metformin is unlikely to be of therapeutic benefit to people with ALS.

Published Results

Comment on this Topic

(All comments are moderated before they appear here.)